C83.50
Lymphoblastic (diffuse) lymphoma, unspecified site
Clinical Classification Guidelines
Medical Intelligence & Overview
Lymphoblastic (diffuse) lymphoma is a type of blood cancer that originates in the lymphatic system, which is part of the immune system. When the exact site of the lymphoma is not specified, it is classified under code C83.50 in the ICD-10 system. This disease involves the abnormal growth of immature lymphocytes, which can spread throughout the lymphatic tissues and other parts of the body. Recognizing the nature of this lymphoma is essential for diagnosis and treatment planning, although the specific location of the disease often remains unspecified in the diagnosis.
Causes & Symptoms
Clinical Causes: Genetic mutations leading to abnormal lymphocyte growth Exposure to certain chemicals or radiation Viral infections, such as Epstein-Barr virus or HIV Immune system disorders, including autoimmune diseases Family history of lymphomas or other blood cancers
Key Symptoms: Swollen lymph nodes, especially in the neck, armpits, or groin Unexplained weight loss Fever that persists over time Night sweats Fatigue or weakness Shortness of breath or cough if the lymph nodes impact the chest Loss of appetite Itching or skin rash in some cases
Diagnostic & Treatment
Diagnosis Path: The diagnosis of lymphoblastic (diffuse) lymphoma involves a combination of clinical examination, laboratory tests, and imaging studies. Key diagnostic steps include:
Treatment Protocols: Treatment strategies for lymphoblastic lymphoma typically involve aggressive chemotherapy regimens aimed at destroying cancer cells. Depending on the individual case, additional therapies may include:
Clinical Advice & FAQs
Billing Guidance
Is C83.50 a billable ICD-10 code?
Yes, C83.50 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C83.50?
Clinical documentation must specify the nature of Lymphoblastic (diffuse) lymphoma, unspecified site and any associated comorbidities for accurate reporting.
Cite this Clinical Reference